Anti PD-L1 DUrvalumab combined with Cetuximab and RadiOtherapy in locally advanced squamous cell carcinoma of the head and neck: A phase I/II study (DUCRO)

Clinical and Translational Radiation Oncology

Cinzia Talamonti¹  Livia Marrazzo¹  Stefania Pallotta¹  Monica Mangoni²  Daniela Greto²  Mauro Loi²  Mariangela Sottili²  Lorenzo Livi²  Pierluigi Bonomo²  Isacco Desideri² 

[1] Medical Physics, Azienda Ospedaliero – Universitaria Careggi, University of Florence, Florence, Italy;Radiation Oncology, Azienda Ospedaliero – Universitaria Careggi, University of Florence, Florence, Italy;

关键词: Radiotherapy;    Head and neck cancer;    Cetuximab;    Durvalumab;    Immunotherapy;   

DOI  :  10.1016/j.ctro.2018.01.005

来源: DOAJ

【 授权许可】

Unknown